NCT02757469

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

Drospirenone and Ethinyl Estradiol Combinations (Yasmin) as Infertility Treatments for Premature Ovarian Failure: a Perspective Follow-up Study.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Navy General Hospital, Beijing · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

Premature ovarian insufficiency (POI) is a life-changing condition that affects women in their reproductive age. There is a lack of reports which focus on how to improve the reproductive outcome of these women who wish to conceive spontaneously or use assisted conception with their own oocytes. However, one could surmise that it is important to lower gonadotropin levels into the physiological range before embarking on any treatment, even if natural conception is the only choice for the woman/couple.

Conditions

• Primary Ovarian Insufficiency
• Menopause, Premature

Interventions

Type	Name	Description
DRUG	Drospirenone and ethinyl estradiol combination (Yasmin)	Female oral combined contraceptive containing 30 mcg (0.030 mg) Ethinyl Estradiol and 3 mg drospirenone (Androstenes)

Timeline

• Start date: 2016-05-01
• Primary completion: 2020-05-01
• Completion: 2021-05-01
• First posted: 2016-05-02
• Last updated: 2016-05-02

Locations

1 site across 1 country: China